Page 132 - Read Online
P. 132
Page 787 Wong et al. Cancer Drug Resist 2023;6:768-87 https://dx.doi.org/10.20517/cdr.2023.58
breast cancer. Expert Opin Investig Drugs 2022;31:567-91. DOI
137. Yap TA, Parkes EE, Peng W, Moyers JT, Curran MA, Tawbi HA. Development of immunotherapy combination strategies in cancer.
Cancer Discov 2021;11:1368-97. DOI
138. Alpuim Costa D, Nobre JG, Batista MV, et al. Human microbiota and breast cancer - Is there any relevant link? - A literature
review and new horizons toward personalised medicine. Front Microbiol 2021;12:584332. DOI
139. Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
Science 2015;350:1084-9. DOI
140. Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science
2015;350:1079-84. DOI
141. Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer
2022;22:703-22. DOI
